Arne Scheu

Company: Valink Therapeutics

Job title: Co-Founder and Chief Executive Officer

Seminars:

Exploring Cutting-Edge Novel Formats of Bispecific Antibodies for Next-Generation Therapeutic Applications 9:35 am

Exploring the landscape of novel bispecific drugs including bispecific antibody-drug conjugates, CAR-T therapies and beyond Leveraging advanced protein engineering techniques to design novel bispecific antibody constructs Case studies highlighting successful applications of novel bispecific antibody formats across various disease indications Optimizing novel antibody formats for enhanced target specificity, affinity, and stability Addressing translational challenges and…Read more

day: Pre-Conference Day Workshop A